These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 6763209)
21. Clinical trials with allergen products--statistical considerations. Volkers P Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):172-80; discussion 181. PubMed ID: 17393737 [No Abstract] [Full Text] [Related]
22. Adaptive design may hasten clinical trials. Schmidt C J Natl Cancer Inst; 2007 Jan; 99(2):108-9. PubMed ID: 17227993 [No Abstract] [Full Text] [Related]
23. How to design a clinical trial. Curtis BM; Barrett BJ; Parfrey PS Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789 [No Abstract] [Full Text] [Related]
24. Clinical considerations in the design of clinical trials. Carter SK Cancer Treat Rep; 1980; 64(2-3):367-71. PubMed ID: 7407773 [TBL] [Abstract][Full Text] [Related]
26. FDA signals it's open to drug trials that shift midcourse. Mathews AW Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817 [No Abstract] [Full Text] [Related]
27. Trend toward noninferiority trials may mean more difficult interpretation of trial results. Tuma RS J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926 [No Abstract] [Full Text] [Related]
28. Mortality trials in cardiovascular medicine. Lewis JA Cardiology; 1994; 84(6):385-90. PubMed ID: 8062304 [TBL] [Abstract][Full Text] [Related]
29. Design using historical controls. Yen A; Simpson E; Haverkamp L; Appel S Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():61-3. PubMed ID: 15512876 [No Abstract] [Full Text] [Related]
30. Clinical trials of analgesic drugs. Cahal DA Proc R Soc Med; 1969 Aug; 62(8):807-9. PubMed ID: 4897492 [No Abstract] [Full Text] [Related]
31. How to deal with multiple endpoints in clinical trials. Neuhäuser M Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645 [TBL] [Abstract][Full Text] [Related]
32. [Clinical studies--what is the putting of the question?]. Guttenberger R Strahlenther Onkol; 1999 Apr; 175 Suppl 1():14-6. PubMed ID: 10230452 [No Abstract] [Full Text] [Related]
33. Patient heterogeneity in clinical trials. Simon R Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777 [TBL] [Abstract][Full Text] [Related]
34. Advantages and drawbacks of the Zelen design for randomized clinical trials. Horwitz RI; Feinstein AR J Clin Pharmacol; 1980 Jul; 20(7):425-7. PubMed ID: 7430410 [No Abstract] [Full Text] [Related]
35. Clinical trials: what you and your patients need to know. Yoder LH Medsurg Nurs; 2005 Oct; 14(5):351-3; quiz 354. PubMed ID: 16318119 [No Abstract] [Full Text] [Related]
36. Evaluating statistics in clinical trials: making the unintelligible intelligible. Gilmore SJ Australas J Dermatol; 2008 Nov; 49(4):177-84; quiz 185-6. PubMed ID: 18855776 [TBL] [Abstract][Full Text] [Related]
37. What is the logic in mixing data and beliefs? Brown PM Pharm Stat; 2007; 6(1):5-8. PubMed ID: 17256805 [No Abstract] [Full Text] [Related]
39. Interpretation of clinical trial results. Practice Committee of American Society for Reproductive Medicine Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606 [TBL] [Abstract][Full Text] [Related]